• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[幽门螺杆菌筛查预防胃癌的成本效益:马尔可夫决策分析]

[Cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: Markov decision analysis].

作者信息

Wang Qian, Jin Pi-huan, Lin Guo-wei, Xu San-rong, Chen Jie

机构信息

Center of Clinical Epidemiology, Huashan Hospital of Fu Dan University, Shanghai 200040, China.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Feb;24(2):135-9.

PMID:12697117
Abstract

OBJECTIVE

Using Markov model Monte Carlo simulation to conduct a cost-effectiveness analysis of screening Helicobacter pylori (H. pylori) infection to prevent gastric cancer.

METHODS

The Markov model was developed based on the natural course from H. pylori infection to gastric cancer. Two strategies were compared: (1) screening for H. pylori and treatment for those with positive tests, and (2) without screening and treatment. Data used for model simulation including transition probability, efficacy of test and treatment were collected from related research publications. Markov model Monte Carlo simulation combined with bootstrap method was used to perform base-case analysis and estimate the confidence interval of cost-effectiveness ratios. The probability sensitivity analysis was used to estimate the cost-effectiveness in multiple uncertainty factors.

RESULTS

Assuming H. pylori eradication will prevent 50% of attribute gastric cancer, the screening strategies would prevent 16.6% cases of gastric cancer. Cost-effectiveness were 10,405 Yuan (95% CI: 4,238 - 27,727 Yuan) per GC prevented, 64 Yuan (95% CI: 31 - 97 Yuan) per QALY saved and 1,374 Yuan (95% CI: 352 - 86,624 Yuan) per life year saved.

CONCLUSION

Screening and treatment for H. pylori infection in population was potentially effective in the prevention of gastric cancer, and screening in high incidence area of gastric cancer would be more effective and economic.

摘要

目的

运用马尔可夫模型蒙特卡罗模拟法,对筛查幽门螺杆菌(H. pylori)感染以预防胃癌进行成本效益分析。

方法

基于H. pylori感染至胃癌的自然病程建立马尔可夫模型。比较两种策略:(1)筛查H. pylori并对检测呈阳性者进行治疗,(2)不进行筛查和治疗。模型模拟所用数据,包括转移概率、检测和治疗效果,均从相关研究出版物中收集。采用马尔可夫模型蒙特卡罗模拟结合自助法进行基础病例分析,并估计成本效益比的置信区间。概率敏感性分析用于估计多种不确定性因素下的成本效益。

结果

假设根除H. pylori可预防50%的归因胃癌,筛查策略可预防16.6%的胃癌病例。每预防一例胃癌的成本效益为10,405元(95%置信区间:4,238 - 27,727元),每挽救一个质量调整生命年(QALY)的成本效益为64元(95%置信区间:31 - 97元),每挽救一个生命年的成本效益为1,374元(95%置信区间:352 - 86,624元)。

结论

人群中筛查和治疗H. pylori感染对预防胃癌可能有效,在胃癌高发地区进行筛查将更有效且经济。

相似文献

1
[Cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: Markov decision analysis].[幽门螺杆菌筛查预防胃癌的成本效益:马尔可夫决策分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Feb;24(2):135-9.
2
Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese.中国幽门螺杆菌筛查预防胃癌的成本效益分析
Int J Technol Assess Health Care. 2008 Winter;24(1):87-95. doi: 10.1017/S0266462307080117.
3
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.胃癌一级和二级预防策略的成本效益分析
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):875-85. doi: 10.1158/1055-9965.EPI-06-0758.
4
Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.展示诊断技术的经济评估:比较加拿大幽门螺杆菌筛查策略在预防胃癌方面的效果
J Am Coll Radiol. 2009 May;6(5):317-23. doi: 10.1016/j.jacr.2009.01.022.
5
Endoscopic screening for gastric cancer.胃癌的内镜筛查
Clin Gastroenterol Hepatol. 2006 Jun;4(6):709-16. doi: 10.1016/j.cgh.2006.03.025.
6
Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer.早期胃癌内镜切除术后根除幽门螺杆菌对胃癌幸存者的成本效益。
Helicobacter. 2009 Dec;14(6):536-44. doi: 10.1111/j.1523-5378.2009.00721.x.
7
The health economics of Helicobacter pylori infection.幽门螺杆菌感染的卫生经济学
Best Pract Res Clin Gastroenterol. 2007;21(2):347-61. doi: 10.1016/j.bpg.2006.11.004.
8
Cost-benefit analysis of Helicobacter pylori screening.
Health Policy. 2004 Oct;70(1):85-96. doi: 10.1016/j.healthpol.2004.02.004.
9
[Study on health economics regarding the screening of gastric cancer in Zhuanghe high risk area].庄河高危地区胃癌筛查的卫生经济学研究
Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Oct;26(10):757-60.
10
Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.幽门螺杆菌感染率高的人群中,对有典型反流症状的患者进行幽门螺杆菌“检测和治疗”的成本效益:马尔可夫模型分析
Scand J Gastroenterol. 2006 Jan;41(1):21-9. doi: 10.1080/00365520510023873.

引用本文的文献

1
Utility Values of Health Status in Gastric Cancer: A Systematic Review.胃癌健康状况的效用值:一项系统评价
Value Health Reg Issues. 2025 Mar;46:101063. doi: 10.1016/j.vhri.2024.101063. Epub 2025 Feb 1.
2
Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical Considerations.大规模根除幽门螺杆菌以预防胃癌:理论与实践考量
Gut Liver. 2016 Jan;10(1):12-26. doi: 10.5009/gnl15091.
3
Cost-benefit analysis of screening for esophageal and gastric cardiac cancer.食管癌和贲门癌筛查的成本效益分析
Chin J Cancer. 2011 Mar;30(3):213-8. doi: 10.5732/cjc.010.10425.
4
Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone.根除幽门螺杆菌以预防胃十二指肠疾病:一石多鸟。
Therap Adv Gastroenterol. 2008 Sep;1(2):111-20. doi: 10.1177/1756283X08094880.
5
Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results.在期待临床试验结果之际,探索幽门螺杆菌筛查在中国预防胃癌的成本效益。
Int J Cancer. 2009 Jan 1;124(1):157-66. doi: 10.1002/ijc.23864.
6
Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.基于人群的血清学筛查和¹³C-尿素呼气试验预防胃癌的成本效益分析:马尔可夫模型
World J Gastroenterol. 2008 May 21;14(19):3021-7. doi: 10.3748/wjg.14.3021.